首页> British journal of pharmacology> Salinomycin exerts anti-colorectal cancer activity by targeting the β-catenin/T-cell factor complex.

Salinomycin exerts anti-colorectal cancer activity by targeting the β-catenin/T-cell factor complex.

导出 OA

翻译打印收藏纠错

第一作者： Zhongyuan,Wang

第一单位： Guangdong Key Laboratory for Genome Stability & Disease Prevention, Carson International Cancer Center, Department of Pharmacology, Shenzhen University Health Science Center, Shenzhen, China.

作者： Zhongyuan,Wang ^[1] ; Liang,Zhou ^[1] ; Yanpeng,Xiong ^[1] ; Shubin,Yu ^[1] ; Huan,Li ^[1] ; Jiaoyang,Fan ^[1] ; Fan,Li ^[2] ; Zijie,Su ^[1] ; Jiaxing,Song ^[1] ; Qi,Sun ^[1] ; Shan-Shan,Liu ^[1] ; Yuqing,Xia ^[1] ; Liang,Zhao ^[1] ; Shiyue,Li ^[1] ; Fang,Guo ^[3] ; Peng,Huang ^[2] ; Dennis A,Carson ^[4] ; Desheng,Lu ^[1]

作者单位： Guangdong Key Laboratory for Genome Stability & Disease Prevention, Carson International Cancer Center, Department of Pharmacology, Shenzhen University Health Science Center, Shenzhen, China. ^[1] Guangdong Key Laboratory for Biomedical Measurements and Ultrasound Imaging, Laboratory of Evolutionary Theranostics, School of Biomedical Engineering, Shenzhen University Health Science Center, Shenzhen, China. ^[2] Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, China. ^[3] Guangdong Key Laboratory for Genome Stability & Disease Prevention, Carson International Cancer Center, Department of Pharmacology, Shenzhen University Health Science Center, Shenzhen, China.;Moores Cancer Center, University of California San Diego (UCSD), La Jolla, California. ^[4]